Doppler Ultrasound Compared With Stethoscope to Assess Heart Rate (HR)

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT04242654
Collaborator
(none)
32
1
2
13.9
2.3

Study Details

Study Description

Brief Summary

This is a prospective randomized controlled trial comparing heart rate measurement by Doppler ultrasound or auscultation with a stethoscope in newborn infants who require stabilization or resuscitation immediately after birth. Enrolled subjects will be randomly assigned to have their heart rate (HR) obtained by stethoscope (ST) or by Doppler ultrasound (DO). Neonates will be resuscitated in accordance with the Neonatal Resuscitation Program (NRP) guidelines.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Handheld fetal doppler ultrasound
N/A

Detailed Description

Obtaining a baby's heart rate (HR) is an important part of neonatal resuscitation in the delivery room and helps the medical team decide how to treat the baby. When babies do not breathe well on their own, the medical team places electrocardiogram (ECG) leads on the baby's chest to obtain an accurate HR rapidly that can be seen by the entire team. Before the ECG leads are placed on the baby's chest, the Neonatal Resuscitation Program (NRP) guidelines suggest that medical team members listen to the baby's HR using a stethoscope for 6 seconds. However, it can take longer than 6 seconds for medical team members to obtain a HR which can delay a baby's care. The purpose of this study is to determine if Doppler ultrasound is a useful, alternative tool, aside from a stethoscope, that can be used to quickly obtain a baby's HR, particularly in high-risk babies. The primary objective will be the time that it takes to obtain a baby's HR by Doppler ultrasound as compared to listening to a baby's HR with a stethoscope. With this study, the investigators will be able to understand if Doppler ultrasound is a useful tool in the resuscitation of babies who are high risk.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized-Controlled Trial of Handheld Doppler Ultrasound Compared With Auscultation by Stethoscope to Assess Heart Rate During the Resuscitation of High-risk Neonates
Actual Study Start Date :
Aug 17, 2020
Actual Primary Completion Date :
Oct 13, 2021
Actual Study Completion Date :
Oct 13, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Doppler ultrasound

Placement of Doppler US on chest to obtain newborn's heart rate.

Procedure: Handheld fetal doppler ultrasound
Handheld fetal doppler ultrasound will be used to assess heart rate in high-risk neonates.

No Intervention: Stethoscope

Placement of stethoscope on chest to obtain newborn's heart rate.

Outcome Measures

Primary Outcome Measures

  1. Time to obtain HR (in seconds) [Up to approximately 1 minute]

    The primary outcome will be the time to obtain heart rate (HR), which will be defined as the time from when the neonate is placed on the radiant warmer to the time the HR is indicated to the entire resuscitation team.

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Hours to 1 Hour
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All neonates admitted to the transitional nursery for resuscitation after delivery
Exclusion Criteria:
  • Neonates with congenital heart disease, congenital diaphragmatic hernia

  • Neonates whose mothers present and will have imminent delivery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Columbia University Irving Medical Center New York New York United States 10032

Sponsors and Collaborators

  • Columbia University

Investigators

  • Principal Investigator: Tina Leone A. Leone, MD, Columbia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Columbia University
ClinicalTrials.gov Identifier:
NCT04242654
Other Study ID Numbers:
  • AAAS5205
First Posted:
Jan 27, 2020
Last Update Posted:
Jan 10, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Columbia University

Study Results

No Results Posted as of Jan 10, 2022